Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 03:06PM ET
1.15
Dollar change
+0.02
Percentage change
2.21
%
Index- P/E- EPS (ttm)-0.80 Insider Own4.62% Shs Outstand11.70M Perf Week1.32%
Market Cap13.61M Forward P/E- EPS next Y-0.73 Insider Trans0.00% Shs Float11.23M Perf Month-12.50%
Income-9.36M PEG- EPS next Q-0.19 Inst Own10.30% Short Float0.77% Perf Quarter5.00%
Sales0.00M P/S- EPS this Y- Inst Trans19.17% Short Ratio2.53 Perf Half Y-20.89%
Book/sh1.06 P/B1.09 EPS next Y- ROA-55.47% Short Interest0.09M Perf Year-3.75%
Cash/sh0.45 P/C2.59 EPS next 5Y- ROE-57.90% 52W Range1.00 - 2.00 Perf YTD13.24%
Dividend Est.- P/FCF- EPS past 5Y22.25% ROI-75.15% 52W High-42.25% Beta0.68
Dividend TTM- Quick Ratio5.59 Sales past 5Y0.00% Gross Margin- 52W Low15.50% ATR (14)0.05
Dividend Ex-Date- Current Ratio5.59 EPS Y/Y TTM-34.45% Oper. Margin0.00% RSI (14)48.41 Volatility2.94% 5.09%
Employees7 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price6.50
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q-19.83% Payout- Rel Volume0.68 Prev Close1.13
Sales Surprise- EPS Surprise5.26% Sales Q/Q- EarningsFeb 16 AMC Avg Volume34.29K Price1.15
SMA20-0.90% SMA50-0.42% SMA200-6.27% Trades Volume20,241 Change2.21%
Date Action Analyst Rating Change Price Target Change
Feb-11-15Initiated Midtown Partners Strong Buy $5.30
Feb-15-24 06:30AM
Feb-14-24 05:11PM
Feb-01-24 06:20AM
Jan-29-24 06:30AM
Jan-04-24 06:30AM
01:32PM Loading…
Nov-29-23 01:32PM
Nov-28-23 06:40AM
Nov-15-23 06:45AM
05:04AM
Nov-14-23 06:45AM
Oct-16-23 06:45AM
Oct-12-23 06:45AM
Sep-27-23 08:45AM
Sep-05-23 06:49AM
Aug-31-23 08:00AM
06:45AM Loading…
Aug-21-23 06:45AM
Jul-19-23 09:15AM
Jul-13-23 08:31AM
Jul-11-23 09:25AM
06:45AM
Jul-06-23 09:00AM
06:45AM
Jun-29-23 03:00PM
06:45AM
Jun-07-23 08:56PM
May-31-23 06:40AM
May-16-23 06:54AM
06:45AM
May-04-23 06:45AM
Apr-25-23 06:45AM
06:45AM Loading…
Apr-17-23 06:45AM
Apr-12-23 01:59PM
Apr-10-23 08:01AM
Apr-04-23 07:45AM
Mar-31-23 11:15AM
Mar-20-23 09:45AM
Mar-08-23 10:45AM
Feb-15-23 06:30AM
Jan-04-23 06:35AM
Dec-05-22 06:45AM
Nov-15-22 06:45AM
Oct-28-22 02:49PM
Oct-27-22 09:25AM
Oct-14-22 06:40AM
Sep-19-22 09:26AM
Aug-10-22 08:00AM
Aug-09-22 06:45AM
Aug-04-22 09:01AM
06:45AM
May-17-22 06:45AM
May-16-22 12:22PM
06:45AM
Apr-25-22 06:45AM
Feb-15-22 06:45AM
Nov-16-21 06:45AM
Nov-15-21 07:31AM
06:45AM
06:18AM
Oct-13-21 06:45AM
Oct-11-21 08:25AM
Oct-05-21 08:31AM
06:45AM
Sep-28-21 09:28AM
Sep-27-21 07:02AM
06:45AM
Sep-22-21 06:45AM
Sep-21-21 02:18PM
Sep-14-21 12:04PM
07:32AM
Jun-28-21 08:28AM
Jun-22-21 12:49PM
May-17-21 06:45AM
Mar-09-21 08:08AM
05:45AM
Mar-02-21 08:01AM
06:15AM
04:43AM
Feb-18-21 04:59AM
Feb-17-21 06:15AM
Feb-08-21 07:40AM
06:15AM
Jan-27-21 06:15AM
Nov-19-20 06:20AM
Nov-18-20 11:49AM
Nov-17-20 06:20AM
Nov-11-20 10:55AM
06:20AM
Oct-15-20 06:15AM
Sep-18-20 05:35PM
Sep-16-20 06:15AM
Sep-08-20 09:10AM
Sep-04-20 06:50AM
Sep-02-20 06:15AM
Aug-31-20 05:00PM
08:40AM
Aug-06-20 01:43PM
Jul-23-20 11:48AM
Jul-21-20 06:15AM
Jul-20-20 06:10PM
Jul-16-20 03:16PM
NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.